According to Deloitte, the capital gain made by Juventus in 2019 in relation to Rolando Mandragora should not have been taken into account. Mandrake was bought in January 2016 by Genoa for 6 million euros plus 6 million bonuses. The Bianconeri sold it in 2018 for 20 million to Udinese, recording a capital gain of 14 million on the balance sheet closed on June 30, 2019. Deloitte notes that Mandrake’s buyout (for 10 million plus 6 million bonuses in January 2021) was likely a mandatory pass rather than an entitlement. Therefore, the loss on the balance sheet ending June 30, 2022 should have been 4 million less and shareholders’ equity should have been 7 million less. Just as the loss for the 2023 financial year – after the sale of Mandrake to Fiorentina – would have been lower by another 7 million.
Source: Tutto Mercato Web
I am Ben Stock and I work in Athletistic as an author. My specialty is covering football news and other related topics. I have been writing for this website since the past 2 years, crafting compelling stories with the latest updates in the sports world. My articles have gained widespread appreciation amongst readers due to their accuracy and depth of research.
